The visualization of neuronal benzodiazepine receptors in the brain by autoradiography and immunohistochemistry.
Recent methodological improvements in receptor autoradiography have enabled the in vitro and in vivo binding of the benzodiazepines in the brain to be visualized and pharmacologically characterized with an anatomical resolution unattainable by biochemical radioligand binding assays. This approach, combined with computerized microdensitometry, can be used not only to map the distribution of benzodiazepine receptors in the brain but also to quantify their regional densities. Furthermore, immunohistochemical studies, using monoclonal antibodies directed against the solubilized and purified GABA/benzodiazepine receptor-ionophore complex, have revealed the distribution of antigenic sites on brain neurons and their processes. The brain regions of intense immunoreactivity are known to contain a high density of GABA-ergic efferents and neuronal-type benzodiazepine receptors. Current trends and prospects in this area of receptor research are briefly reviewed.
D000818:Animals; D000911:Antibodies, Monoclonal; D001345:Autoradiography; D001921:Brain / Q000378:metabolism*; D007120:Immunochemistry; D051381:Rats; D011963:Receptors, GABA-A / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D011963:Receptors, GABA-A